MEDLIVE (02192) issued 275,000 shares due to the exercise of stock warrants.

date
17:30 08/04/2026
avatar
GMT Eight
Yimaitong (02192) announced that, according to the first pre-emptive purchase rights plan adopted by the company on March 29, 2021, two directors of the company exercised their purchase rights on April 8, 2026 to issue 275,000 ordinary shares.
MEDLIVE (02192) announces that in accordance with the company's first public offering pre-emptive rights plan adopted on March 29, 2021, two directors of the company exercised their pre-emptive rights to subscribe for 275,000 ordinary shares on April 8, 2026.